Tetrakis [cu (Draximage Sestamibi, Cardiolite) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Aug 10, 2026
Some Tetrakis [cu products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 3
In shortage since
May 15, 2026
Reports on file
12
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
DRAXIMAGE SESTAMIBI
1MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
DIN 02327732 · since May 15, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended May 15, 2026 · Disruption of the manufacture of the drug.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended Mar 13, 2026 · Disruption of the manufacture of the drug.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended Dec 30, 2025 · Disruption of the manufacture of the drug.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended Oct 21, 2025 · Demand increase for the drug.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended Jun 10, 2025
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended Apr 3, 2023 · Delay in shipping of the drug.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · POWDER FOR SOLUTION
KIT · CURIUM CANADA INC
DIN 02329794 · ended Feb 20, 2023
Resolved
CARDIOLITE
1MG · POWDER FOR SOLUTION · LANTHEUS MI CANADA INC
DIN 02328003 · ended Feb 21, 2022 · Shortage of an active ingredient.
Resolved
DRAXIMAGE SESTAMIBI
1MG · POWDER FOR SOLUTION · JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
DIN 02327732 · ended Dec 13, 2021 · Delay in product release.
The product will become available by end of the day December 13, 2021.
Resolved
KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION
1MG · KIT
POWDER FOR SOLUTION · CURIUM CANADA INC
DIN 02329794 · ended Feb 15, 2021 · Disruption of the manufacture of the drug.
What's happening
Tetrakis [cu is currently affected by an active shortage report filed with Health Canada by JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
Aug 10, 2026
New report filed
Common questions
When will Tetrakis [cu be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Tetrakis [cu in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.